Ładuje się......
Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide
CONTEXT: Diazoxide, the only U.S. Food and Drug Administration–approved drug to treat hyperinsulinemic hypoglycemia, has been associated with several adverse events, which has raised concerns about the safety of this drug. Existing reports are limited to small studies and case reports. OBJECTIVE: To...
Zapisane w:
| Wydane w: | J Clin Endocrinol Metab |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Endocrine Society
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207144/ https://ncbi.nlm.nih.gov/pubmed/30247666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01613 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|